In vitro studies with cefazaflur and other parenteral cephalosporins.
Paul Actor, Joseph R. Guarini, Joseph V. Uri, HENRY F. BARTUS, IHOR ZAJAC, Jerry A. Weisbach
Abstract
Open-access reader
Paul Actor, Joseph R. Guarini, Joseph V. Uri, HENRY F. BARTUS, IHOR ZAJAC, Jerry A. Weisbach
Abstract
Open-access reader
Cefazaflur has a broad-spectrum of in vitro antibacterial activity equal to or greater than that of the commercially-available cephalosporins. In addition, cefazaflur has activity against isolates of Enterobacter, Citrobacter and indole-positive Proteus; however, this activity decreased markedly when the MIC determinations were carried out with a large inoculum size. A similar inoculum effect was observed with cefamandole, however, cefoxitin's activity was relatively unchanged at increased inoculum sizes. Human serum had a relatively small effect on the in vitro activity of cefazaflur.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cefazaflur has a broad-spectrum of in vitro antibacterial activity equal to or greater than that of the commercially-available cephalosporins. In addition, cefazaflur has activity against isolates of Enterobacter, Citrobacter and indole-positive Proteus; however, this activity decreased markedly when the MIC determinations were carried out with a large inoculum size. A similar inoculum effect was observed with cefamandole, however, cefoxitin's activity was relatively unchanged at increased inoculum sizes. Human serum had a relatively small effect on the in vitro activity of cefazaflur.
Key concepts: Cefoxitin, Cefamandole, Cephalosporin, Enterobacter, Proteus, In vitro, Citrobacter, Microbiology